Gland Pharma has a battle on its hands
The Hyderabad-based contract manufacturer has seen its big European bet sour. Can its new CEO move mountains?
20 November, 2024•12 min
0
20 November, 2024•12 min
0
Getting your Trinity Audio player ready...
Why read this story?
Editor's note: Gland Pharma has a battle on its hands
More in Business
Business
Infra.Market’s debt binge before IPO sets alarm bells ringing
The platform’s pre-IPO debt funding raises fresh questions about cash flows and SEBI’s role. Investors will do well to take note.
You may also like
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Business
How Glenmark convinced its investors to back its high-risk R&D strategy
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
